Our Consumer Healthcare business develops and markets consumer preferred and expert recommended brands in the Oral health, Pain relief, Respiratory, Nutrition/gastro-intestinal and Skin health categories.
We are one of the world’s leading over-the-counter healthcare companies. We hold number one positions in Wellness across 36 markets, and are market leaders in specialist oral care.
We have a portfolio of loved and trusted brands that are underpinned by science including: Sensodyne, Parodontax, Poligrip, Voltaren, Panadol, Otrivin and Theraflu.
The business generated sales of £7.8 billion in 2017, representing 26% of the total turnover of the Group.
On 19 December 2018 we announced our agreement with Pfizer to form a new world-leading Consumer Healthcare Joint Venture. Within 3 years of the closing of the transaction, we intend to separate the Joint Venture via a demerger. With our future intention to separate, the transaction also presents a clear pathway forward for us to create a new global Pharmaceuticals/Vaccines company, and a new world-leading Consumer Healthcare company. Find out more
Today, people are taking an increasingly active role in managing their own health. This is being fuelled by an emerging global middle class, rising healthcare costs and ageing populations. Demand for consumer healthcare products is growing, particularly in emerging markets where consumers are seeking more affordable and accessible products.
Consumer healthcare products are dependent on brand loyalty and trademark protection. Some of our heritage brands such as ENO are more than 140 years old but continue to be popular today.
Our strategy is to meet the everyday healthcare needs of our consumers through building consumer preferred and expert recommended brands.
To do this we focus on excellence in innovation to develop world class brands, and on building our reputation through best in class interactions with retailers, healthcare professionals and shoppers.
Research for product innovation
Our business is built on science and this research heritage contributes to the development of our Consumer Healthcare products, giving us a unique advantage over our competition.
Today, we are using science to speed up the time to develop new product innovations, make them more accessible to the people who need them, and to develop benefits our consumers value, ultimately growing our business.
At the same time, we continue to ensure we meet all regulatory requirements for testing, approval, manufacturing, labelling and marketing of our products.
You can find out more about our R&D work on Consumer Healthcare products in our Research section.
If you have a product idea and believe we might like to partner with you, please visit our Consumer Healthcare External Innovation portal.
Other business areas
Our Pharmaceuticals business is made up of innovative and established medicines and holds leading market positions in respiratory disease and HIV.
Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. We deliver over two million vaccine doses per day to people living in over 160 countries.
Find out more about us
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business
It began when Plough Court Pharmacy was established in 1715. Discover GSK's journey through the centuries that led to the organisation we know today
Our consumer healthcare products
When you experience discomforts like sensitive teeth, colds and flu or joint pain, our everyday healthcare products are here to help you enjoy life to the full again.
Consumer healthcare research
GSK products are built around science, and it is this innovation that is vital to our Consumer Healthcare business